BioVie Inc. (BIVI)

NASDAQ: BIVI · Real-Time Price · USD

2.180

+0.180 (9.00%)

At close: Jan 2, 2025, 4:00 PM

2.150

-0.030 (-1.38%)

After-hours: Jan 2, 2025, 4:30 PM EST

BioVie Employees

BioVie had 14 employees as of June 30, 2024. The number of employees decreased by 4 or -22.22% compared to the previous year.

Employees

14

Change (1Y)

-4

Growth (1Y)

-22.22%

Revenue / Employee

n/a

Profits / Employee

-$1,912,398

Market Cap

38.68M

Employees Chart

Employees History

Date	Employees	Change	Growth
Jun 30, 2024	14	-4	-22.22%
Jun 30, 2023	18	5	38.46%
Jun 30, 2022	13	7	116.67%
Jun 30, 2021	6	2	50.00%
Jun 30, 2020	4	-1	-20.00%
Jun 30, 2019	Pro	Pro	Pro
Jun 30, 2018	Pro	Pro	Pro
Jun 30, 2015	Pro	Pro	Pro
Jun 30, 2014	Pro	Pro	Pro

Related Stocks

Company Name	Employees
UnitedHealth Group	440,000
Johnson & Johnson	131,900
Thermo Fisher Scientific	122,000
Abbott Laboratories	114,000
AstraZeneca	89,900
Novartis AG	76,057
Merck & Co.	72,000
Novo Nordisk	64,319

Employee Rankings

BIVI News

6 hours ago - Bronstein, Gewirtz & Grossman, LLC Encourages BioVie Inc. (BIVI) Stockholders to Inquire about Securities Investigation - Accesswire
4 days ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against BioVie Inc. (BIVI) and Encourages Investors to Learn More About the Investigation - Accesswire
9 days ago - Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against BioVie Inc. (BIVI) And Encourages Investors to Reach Out - Accesswire
11 days ago - Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against BioVie Inc. (BIVI) And Encourages Stockholders to Reach Out - Accesswire
15 days ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating BioVie Inc. (BIVI) And Encourages Stockholders to Connect - Accesswire
18 days ago - BioVie Inc. (BIVI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - Accesswire
22 days ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against BioVie Inc. (BIVI) and Encourages Stockholders to Learn More About the Investigation - Accesswire
2 months ago - UPDATE -- BioVie Inc. Announces Pricing of Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - GlobeNewsWire